What computational non-targeted mass spectrometry-based metabolomics can gain 
from shotgun proteomics

Hamzeiy, Hamid; Cox, Jürgen

doi:10.1016/j.copbio.2016.11.014

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

What computational non-targeted mass spectrometry-based metabolomics can gain from shotgun proteomics

MPS-Authors

/persons/resource/persons208751

Hamzeiy, Hamid
Cox, Jürgen / Computational Systems Biochemistry, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons77870

Cox, Jürgen
Cox, Jürgen / Computational Systems Biochemistry, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

1-s2.0-S0958166916302749-main.pdf
(出版社版), 2MB

付随資料 (公開)

There is no public supplementary material available

引用

Hamzeiy, H., & Cox, J. (2017). What computational non-targeted mass spectrometry-based metabolomics can gain from shotgun proteomics. Current Opinion in Biotechnology, 43, 141-146. doi:10.1016/j.copbio.2016.11.014.

引用: https://hdl.handle.net/11858/00-001M-0000-002D-CD96-2

要旨

Computational workflows for mass spectrometry-based shotgun proteomics and untargeted metabolomics share many steps. Despite the similarities, untargeted metabolomics is lagging behind in terms of reliable fully automated quantitative data analysis. We argue that metabolomics will strongly benefit from the adaptation of successful automated proteomics workflows to metabolomics. MaxQuant is a popular platform for proteomics data analysis and is widely considered to be superior in achieving high precursor mass accuracies through advanced nonlinear recalibration, usually leading to five to ten-fold better accuracy in complex LC-MS/MS runs. This translates to a sharp decrease in the number of peptide candidates per measured feature, thereby strongly improving the coverage of identified peptides. We argue that similar strategies can be applied to untargeted metabolomics, leading to equivalent improvements in metabolite identification.